Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35093460)

  • 1. Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides.
    Tian Z; Zhao Y; Mai Y; Qiao F; Guo J; Dong L; Niu Y; Gou G; Yang J
    Int J Pharm; 2022 Mar; 616():121522. PubMed ID: 35093460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of particle shapes on the oral delivery of drug nanocrystals: Mucus permeation, transepithelial transport and bioavailability.
    Guo M; Wei M; Li W; Guo M; Guo C; Ma M; Wang Y; Yang Z; Li M; Fu Q; Yang L; He Z
    J Control Release; 2019 Aug; 307():64-75. PubMed ID: 31207275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer.
    Tian Z; Wu X; Peng L; Yu N; Gou G; Zuo W; Yang J
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124819. PubMed ID: 37178894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus-penetrating dendritic mesoporous silica nanoparticle loading drug nanocrystal clusters to enhance permeation and intestinal absorption.
    Zhou W; Li B; Min R; Zhang Z; Huang G; Chen Y; Shen B; Zheng Q; Yue P
    Biomater Sci; 2023 Jan; 11(3):1013-1030. PubMed ID: 36545798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane Pathways and Mechanisms of Rod-like Paclitaxel Nanocrystals through MDCK Polarized Monolayer.
    Deng F; Zhang H; Wang X; Zhang Y; Hu H; Song S; Dai W; He B; Zheng Y; Wang X; Zhang Q
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5803-5816. PubMed ID: 28116899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers.
    Mu S; Li M; Guo M; Yang W; Wang Y; Li J; Fu Q; He Z
    Colloids Surf B Biointerfaces; 2016 Nov; 147():73-80. PubMed ID: 27490456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on
    Zhu Y; Hu F; Shen C; Shen B; Yuan H
    Pharm Dev Technol; 2024 Jun; ():1-8. PubMed ID: 38808380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport Mechanisms of Butyrate Modified Nanoparticles: Insight into "Easy Entry, Hard Transcytosis" of Active Targeting System in Oral Administration.
    Wu L; Bai Y; Liu M; Li L; Shan W; Zhang Z; Huang Y
    Mol Pharm; 2018 Sep; 15(9):4273-4283. PubMed ID: 30102863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
    Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Mucin Induces More Endocytosis but Less Transcytosis of Nanoparticles across Enterocytes by Triggering Nanoclustering and Strengthening the Retrograde Pathway.
    Yang D; Liu D; Qin M; Chen B; Song S; Dai W; Zhang H; Wang X; Wang Y; He B; Tang X; Zhang Q
    ACS Appl Mater Interfaces; 2018 Apr; 10(14):11443-11456. PubMed ID: 29485849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways.
    Zhu Y; Fu Y; Zhang A; Wang X; Zhao Z; Zhang Y; Yin T; Gou J; Wang Y; He H; Tang X
    Eur J Pharm Sci; 2022 Jan; 168():106047. PubMed ID: 34687899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.